BIZTRAC BETA
Retail sale of pharmaceutical products

STØPERIGÅRDEN APOTEK AS

Org. no. 928948013 Limited company (AS) Stavanger Incorporated 2022 Active
Ownership graph ↗
Revenue 2025 NOK 26.9m
Operating profit NOK 2.8m
Equity NOK 228,000
Incorporated 2022
Employees 8
Share capital NOK 30,000

STØPERIGÅRDEN APOTEK AS is registered as a limited company in Stavanger, Rogaland with organisation number 928948013. The business is classified under retail sale of pharmaceutical products (NACE 47.730). The company was incorporated in 2022 and has 8 registered employees. Registered share capital is NOK 30,000, divided into 10000 shares. The company's stated purpose is: “Eie og drive apotek, samt naturlig tilhørende virksomhet.”. The most recent filed accounts, for the 2025 financial year, show NOK 26.9m in revenue and NOK 2.8m in operating profit.

Key figures · 2025

Revenue
NOK 26.9m
Operating profit
NOK 2.8m
Equity
NOK 228,000
Est. value
NOK 9.0m

Financial health · 2025

Liquidity
0.93
Weak
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
2.6%
Not satisfactory
Equity as a share of total capital

Who owns STØPERIGÅRDEN APOTEK AS?

SIRA INVEST AS
STØPERIGÅRDEN APOTEK AS
NOK 26.9m rev. · NOK 2.8m profit

STØPERIGÅRDEN APOTEK AS has 1 registered shareholder:

All shareholders and roles →

Frequently asked questions about STØPERIGÅRDEN APOTEK AS

Who owns STØPERIGÅRDEN APOTEK AS?

SIRA INVEST AS is the largest registered owner, with 100.0%.

What is the revenue of STØPERIGÅRDEN APOTEK AS?

STØPERIGÅRDEN APOTEK AS had revenue of NOK 26.9m in 2025.

Who is the general manager of STØPERIGÅRDEN APOTEK AS?

Linn Sarah Aase is registered as general manager of STØPERIGÅRDEN APOTEK AS.

Where is STØPERIGÅRDEN APOTEK AS based?

STØPERIGÅRDEN APOTEK AS has its business address in Stavanger.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.